About Protyon

Protyon provides an analysis service examines the effect of mutations in specific proteins targeted for treatment in lung cancer.

Company Highlights
Year Founded

2022

icon-altEmployees

7

Location (HQ)

NLD

Since Last Funding

1 year 4 months

Monthly Website Visitors

3.1K

icon-altTotal Investment Amt

$700K

Last Funding Round

Pre Seed

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Hospitals and Health Care

Clinical Trials

Health Diagnostics

Hospital & Health Care

Therapeutics